Collectively, these results indicate that lnc-CRAT40 acts as a scaffold to recruit YBX1 to the RelA promoter, promoting RelA transcription, activating NF-κB signaling, and driving CRC progression. Here, YBX1 is linked to colorectal carcinoma.